Subgroup analysis | Number of estimates | Random effect The summary OR (95% CI) | Ratio of ORs (95% CI) | I 2 (%)* | P value* |
Outcome | |||||
Colorectal adenoma | 4 | 0.67 (0.40 to 1.14) | |||
Colorectal cancer | 4 | 0.83 (0.66 to 1.06) | 1.11 (0.54 to 2.28) | 59.48 | 0.73 |
Sex | |||||
Women | 2 | 0.59 (0.13 to 2.74) | |||
Men | 3 | 1.13 (0.81 to 1.58) | 1.46 (0.03 to 63.5) | 45.89 | 0.70 |
Subregion | |||||
Eastern Asia | 7 | 0.75 (0.57 to 1.00) | |||
Western Asia | 1 | 0.69 (0.36 to 1.34) | 0.92 (0.28 to 2.99) | 59.79 | 0.87 |
Blood sample type | |||||
Serum | 3 | 0.52 (0.34 to 0.80) | |||
Plasma | 4 | 0.77 (0.59 to 1.00) | 1.49 (0.73 to 3.03) | 22.67 | 0.21 |
Range | |||||
≤15 ng/mL | 4 | 0.93 (0.70 to 1.25) | |||
>15 ng/mL | 4 | 0.62 (0.47 to 0.83) | 0.65 (0.39 to 1.07) | 28.48 | 0.08 |
*I2 and p value related to subgroup differences.
I2, per cent residual variation due to heterogeneity.